scholarly journals Analysis of Long Noncoding RNAs in Aila-Induced Non-Small Cell Lung Cancer Inhibition

2021 ◽  
Vol 11 ◽  
Author(s):  
Lin Chen ◽  
Cui Wu ◽  
Heming Wang ◽  
Sinuo Chen ◽  
Danhui Ma ◽  
...  

Non-small cell lung cancer (NSCLC) has the highest morbidity and mortality among all carcinomas. However, it is difficult to diagnose in the early stage, and current therapeutic efficacy is not ideal. Although numerous studies have revealed that Ailanthone (Aila), a natural product, can inhibit multiple cancers by reducing cell proliferation and invasion and inducing apoptosis, the mechanism by which Aila represses NSCLC progression in a time-dependent manner remains unclear. In this study, we observed that most long noncoding RNAs (lncRNAs) were either notably up- or downregulated in NSCLC cells after treatment with Aila. Moreover, alterations in lncRNA expression induced by Aila were crucial for the initiation and metastasis of NSCLC. Furthermore, in our research, expression of DUXAP8 was significantly downregulated in NSCLC cells after treatment with Aila and regulated expression levels of EGR1. In conclusion, our findings demonstrate that Aila is a potent natural suppressor of NSCLC by modulating expression of DUXAP8 and EGR1.

Epigenomics ◽  
2020 ◽  
Vol 12 (19) ◽  
pp. 1751-1763
Author(s):  
Sachin Kumar ◽  
Monu Pandey ◽  
Surender K Sharawat

We aim to discuss comprehensively the role of long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) in small-cell lung cancer (SCLC) biology and their clinical utility as cancer biomarkers. We searched the scientific literature to select articles related to the role of lncRNAs and circRNAs in SCLC biology or as cancer biomarkers. We identified that a number of lncRNAs and circRNAs can regulate key biological processes involved in SCLC development, including cell proliferation, metastasis and chemoresistance mainly acting as miRNA sponges. Also, the expression of a few lncRNAs and circRNAs predicted survival outcome depicting their utility as prognostic biomarkers. Further investigations on the role of lncRNAs and circRNAs in SCLC tumors may yield novel therapeutic targets for SCLC.


2019 ◽  
Vol 20 (3) ◽  
pp. 143-153 ◽  
Author(s):  
Cuifang Teng ◽  
Guolin Huang ◽  
Yanmei Luo ◽  
Yingxing Pan ◽  
Hanlin Wang ◽  
...  

2016 ◽  
Vol 33 (2) ◽  
Author(s):  
Biagio Ricciuti ◽  
Clelia Mencaroni ◽  
Luca Paglialunga ◽  
Francesco Paciullo ◽  
Lucio Crinò ◽  
...  

2019 ◽  
Vol 18 ◽  
pp. 153303381882302 ◽  
Author(s):  
Shenglan Gao ◽  
Ziying Lin ◽  
Chunyan Li ◽  
Yahong Wang ◽  
Lawei Yang ◽  
...  

Long noncoding RNAs are capable of regulating gene expression at multiple levels. These RNA molecules are also involved in a variety of physiological and pathological processes. Emerging data demonstrate that a series of differentially expressed long noncoding RNAs are implicated in tumorigenesis. In the present study, we used microarray analysis to identify long noncoding RNAs that are dysregulated in non-small-cell lung cancer when compared to normal lung tissues. Accordingly, we performed quantitative real-time polymerase chain reaction to analyze the levels of long noncoding RNA and the cis target gene. We further found the oncogene property of long noncoding RNA that long noncoding RNA downexpression inhibits non-small-cell lung cancer cells proliferation and migration based on 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide and colony formation assays and wound healing as well as transwell assays. The influence of long noncoding RNA on cell cycle of non-small-cell lung cancer cells is also analyzed by flow cytometry. Among the dysregulated long noncoding RNAs, we identified INS-IGF2 readthrough, transcript variant 1, noncoding RNA (NR_003512.3) is upregulated in non-small-cell lung cancer tissues, the cis gene of which is insulin-like growth factor 2 gene hinted by bioinformatics analysis. We also observed that downregulation of INS-IGF2 readthrough, transcript variant 1, noncoding RNA reduces insulin-like growth factor 2 messenger RNA expression. Furthermore, INS-IGF2 readthrough, transcript variant 1, noncoding RNA downregulation suppresses non-small-cell lung cancer cell proliferation and migration. This downregulation results in a concomitant inhibition of the G1/S transition in non-small-cell lung cancer cells. Our findings suggest that INS-IGF2 readthrough, transcript variant 1, noncoding RNA may be an oncogene involved in the development of lung cancer. Therefore, we speculate that INS-IGF2 readthrough, transcript variant 1, noncoding RNA represents a potential therapeutic target for lung cancer.


RSC Advances ◽  
2019 ◽  
Vol 9 (66) ◽  
pp. 38735-38744
Author(s):  
Xianfang Wang ◽  
Jun Shi ◽  
Ying Chen ◽  
Caihong Wang ◽  
Huifang Shi ◽  
...  

Long noncoding RNAs (lncRNAs) are implicated in the development of chemoresistance in many cancers.


Author(s):  
Panagiotis Paliogiannis ◽  
Valentina Scano ◽  
Arduino Aleksander Mangoni ◽  
Antonio Cossu ◽  
Giuseppe Palmieri

RSC Advances ◽  
2018 ◽  
Vol 8 (71) ◽  
pp. 40846-40855 ◽  
Author(s):  
Qian Li ◽  
Kai Chen ◽  
Rong Dong ◽  
Hengxiao Lu

Dysregulated long noncoding RNAs (lncRNAs) have been frequently observed in various cancers including non-small cell lung cancer (NSCLC) and are closely associated with cancer progression.


Oncotarget ◽  
2016 ◽  
Vol 8 (3) ◽  
pp. 3957-3968 ◽  
Author(s):  
Wei Jing ◽  
Nandi Li ◽  
Yingchao Wang ◽  
Xuefang Liu ◽  
Shengjun Liao ◽  
...  

2012 ◽  
Vol 18 (3 Supplement) ◽  
pp. A4-A4
Author(s):  
Daiana D. Becker-Santos ◽  
Ewan E. Gibb ◽  
Emily A. Vucic ◽  
Katey S.S. Enfield ◽  
Greg L. Stewart ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document